Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases
- PMID: 21565895
- PMCID: PMC3932662
- DOI: 10.1258/ebm.2011.010389
Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases
Abstract
Chemokines and their receptors are implicated in a wide range of human diseases, including acquired immune deficiency syndrome (AIDS). The entry of human immunodeficiency virus type 1 (HIV-1) into a cell is initiated by the interaction of the virus's surface envelope proteins with two cell surface components of the target cell, namely CD4 and a chemokine co-receptor, usually CXCR4 or CCR5. Typical anti-HIV-1 agents include protease and reverse transcriptase inhibitors, but the targets of these agents tend to show rapid mutation rates. As such, strategies based on HIV-1 co-receptors have appeal because they target invariant host determinants. Chemokines and their receptors are also of general interest since they play important roles in numerous physiological and pathological processes in addition to AIDS. Therefore, intensive basic and translational research is ongoing for the dissection of their structure - function relationships in an effort to understand the molecular mechanism of chemokine - receptor interactions and signal transductions across cellular membranes. This paper reviews and discusses recent advances and the translation of new knowledge and discoveries into novel interventional strategies for clinical application.
Similar articles
-
gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.J Neurochem. 2000 Jun;74(6):2373-9. doi: 10.1046/j.1471-4159.2000.0742373.x. J Neurochem. 2000. PMID: 10820198
-
A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.Blood. 1999 Aug 15;94(4):1165-73. Blood. 1999. PMID: 10438703
-
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.Nat Med. 1997 Nov;3(11):1259-65. doi: 10.1038/nm1197-1259. Nat Med. 1997. PMID: 9359702
-
HIV-1 infection and chemokine receptor modulation.Curr HIV Res. 2004 Jan;2(1):39-50. doi: 10.2174/1570162043484997. Curr HIV Res. 2004. PMID: 15053339 Review.
-
[Deep lung--cellular reaction to HIV].Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Rev Port Pneumol. 2007. PMID: 17492233 Review. Portuguese.
Cited by
-
Expression of chemokine receptors on peripheral blood T cells in children with chronic kidney disease.Mediators Inflamm. 2015;2015:536894. doi: 10.1155/2015/536894. Epub 2015 Mar 18. Mediators Inflamm. 2015. PMID: 25866451 Free PMC article.
-
Structural basis of dimerization of chemokine receptors CCR5 and CXCR4.Nat Commun. 2023 Oct 13;14(1):6439. doi: 10.1038/s41467-023-42082-z. Nat Commun. 2023. PMID: 37833254 Free PMC article.
-
Dissecting the biochemical architecture and morphological release pathways of the human platelet extracellular vesiculome.Cell Mol Life Sci. 2018 Oct;75(20):3781-3801. doi: 10.1007/s00018-018-2771-6. Epub 2018 Feb 9. Cell Mol Life Sci. 2018. PMID: 29427073 Free PMC article.
-
Current Status of 68Ga-Pentixafor in Solid Tumours.Diagnostics (Basel). 2022 Sep 2;12(9):2135. doi: 10.3390/diagnostics12092135. Diagnostics (Basel). 2022. PMID: 36140541 Free PMC article. Review.
-
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.Mini Rev Med Chem. 2015;15(13):1063-72. doi: 10.2174/138955751513150923094709. Mini Rev Med Chem. 2015. PMID: 26420723 Free PMC article. Review.
References
-
- Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nat Med. 1996;2:1174–8. - PubMed
-
- Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994;12:593–633. - PubMed
-
- Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657–700. - PubMed
-
- Fernandez EJ, Lolis E. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol. 2002;42:469–99. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials